NASDAQ:CHTP - Chelsea Therapeutics International Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), associated with primary autonomic failure and falls related to NOH in Parkinson's Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension (IDH), fibromyalgia, adult attention deficit hyperactivity disorder (ADHD), chronic fatigue syndrome (CFS), freezing of gait in PD and Down syndrome. In addition, the Company is developing a portfolio of metabolically inert antifolates for the treatment of rheumatoid arthritis and is exploring potential applications in multiple other autoimmune disorders.

Receive CHTP News and Ratings via Email

Sign-up to receive the latest news and ratings for CHTP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:CHTP
CUSIPN/A
Phone+1-704-3411516

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Chelsea Therapeutics International (NASDAQ:CHTP) Frequently Asked Questions

What is Chelsea Therapeutics International's stock symbol?

Chelsea Therapeutics International trades on the NASDAQ under the ticker symbol "CHTP."

Has Chelsea Therapeutics International been receiving favorable news coverage?

Headlines about CHTP stock have been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Chelsea Therapeutics International earned a coverage optimism score of 0.8 on InfoTrie's scale. They also assigned headlines about the healthcare company a news buzz of 7.0 out of 10, meaning that recent news coverage is likely to have an impact on the stock's share price in the immediate future.

What other stocks do shareholders of Chelsea Therapeutics International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chelsea Therapeutics International investors own include CytRx (CYTR), Plug Power (PLUG), SLS International (SLS), Ariad Pharmaceuticals (ARIA), DryShips (DRYS), Rexahn Pharmaceuticals (RNN), GT Advanced Technologies (GTATQ), Avanir Pharmaceuticals (AVNR), Dynavax Technologies (DVAX) and Progenics Pharmaceuticals (PGNX).

How do I buy shares of Chelsea Therapeutics International?

Shares of CHTP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Chelsea Therapeutics International's official website?

The official website for Chelsea Therapeutics International is http://www.chelseatherapeutics.com.

How can I contact Chelsea Therapeutics International?

Chelsea Therapeutics International's mailing address is 3530 Toringdon Way Ste 200, CHARLOTTE, NC 28277-3436, United States. The healthcare company can be reached via phone at +1-704-3411516.


MarketBeat Community Rating for Chelsea Therapeutics International (NASDAQ CHTP)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  104 (Vote Outperform)
Underperform Votes:  79 (Vote Underperform)
Total Votes:  183
MarketBeat's community ratings are surveys of what our community members think about Chelsea Therapeutics International and other stocks. Vote "Outperform" if you believe CHTP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHTP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/22/2019 by MarketBeat.com Staff

Featured Article: What is the S&P 500 Index?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel